Claudia Ulbrich, Cardior 🇩🇪 | Being the Founder of a Rare €1B Exit | E15

We’re in Hannover 🇩🇪 with the founder and CEO of Cardior, Claudia Ulbrich


We talked about Cardior’s recent €1B exit to Novo Nordisk. We also talk about miRNA and Cardiovascular, and why she earned the funny nickname “Frau Biotech”.


💎 ABOUT THE SPEAKER

Claudia has been founding biotechs since the ’90s. She founded her first biotech company, LipoNova AG in 1998 and went on to co-found many more, including Cardior Pharmaceuticals. During her time she has launched and brought public a cancer vaccine company, helped see through a multi-million dollar deal of over €20M, and much more.


🔗 LINKS MENTIONED

- Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=167038


📜 TRANSCRIPT

Read the full transcript here:


🫶 FOLLOW US

- Newsletter: http://eepurl.com/h_fnmH

- LinkedIn: https://www.linkedin.com/company/flot-bio/

- X: https://x.com/FlotBio


🎙️ ABOUT FLOT.BIO

Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 15k monthly views. Free.


⭐️ SPONSORSHIP

Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!


🙏 LIKE/FOLLOW/REVIEW

Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.


⏰ TIMESTAMPS

[00:00:00] Intro
[00:01:47] Novo Nordisk deal
[00:10:19] Results from heart disease phase1
[00:19:55] MicroRNA
[00:26:42] The history of Cardior
[00:41:49] Working with Centerview
[00:45:17] Frau Biotech
[00:53:57] Thanks for listening